Target RWE Acquires NoviSci Inc.
January 15, 2021
Target RWE, a Durham-based real-world evidence solutions company, has acquired NoviSci, Inc., a software analytics and services firm that applies epidemiologic methods and causal inference to health data. Amgen Inc. also made a strategic investment in the combined company, joining existing investors Norwest Venture Partners and 22C Capital to support growth; financial terms were not disclosed.
- Buyers
- Target RWE, Amgen Inc., Norwest Venture Partners, 22C Capital
- Targets
- NoviSci, Inc.
- Industry
- Healthcare Services
- Location
- North Carolina, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Novi Labs Acquires RBN Energy
May 31, 2026
AI & Machine Learning
Novi Labs, an AI-driven energy intelligence company, announced the acquisition of RBN Energy, a Houston-based energy market intelligence, analytics, consulting, and education firm. The combined platform is intended to unify upstream forecasting and asset analytics with commodity market and midstream intelligence to provide a more complete view of energy asset economics across North America.
-
United BioSource (UBC) Acquires Evidinno Outcomes Research
January 5, 2026
Healthcare Services
United BioSource LLC (UBC) acquired Evidinno Outcomes Research Inc., a Vancouver-based healthcare research consulting firm specializing in real-world evidence (RWE), epidemiology, evidence synthesis, and health economics/HEOR. The acquisition will expand UBC’s evidence generation and late-stage/post-approval capabilities, with Evidinno operating as a wholly owned subsidiary.
-
Thermo Fisher Scientific Acquires CorEvitas from Audax Private Equity
July 6, 2023
Data & Analytics
Thermo Fisher Scientific agreed to acquire CorEvitas, a Waltham, Massachusetts–based real-world evidence (RWE) and clinical registries provider, from Audax Private Equity for $912.5 million in cash. The acquisition, completed August 14, 2023, will fold CorEvitas (approximately 300 employees; expected 2023 revenue ~$110M) into Thermo Fisher’s Laboratory Products and Biopharma Services segment to expand its RWE and life‑sciences data capabilities.
-
Target RWE Acquires Curation Team from Ciox Health
August 24, 2022
Healthcare Services
Durham-based real-world evidence company Target RWE acquired the legacy Real World Data curation team from Ciox Health, adding roughly 35 full-time and part-time employees and expanding its data abstraction and curation capabilities. The acquisition strengthens Target RWE's RWD solutions and complements its prior analytics purchase (NoviSci) as the company scales its RWE offerings.
-
Rocscience Inc. Acquires NovoTech Software
October 6, 2021
Software
Rocscience Inc., a Toronto-based developer of geotechnical engineering software, has acquired Vancouver-based NovoTech Software. The deal expands Rocscience's geotechnical product capabilities and brings NovoTech's CTO and web application team into Rocscience while NovoTech continues to operate under its name in the near term.
-
WCG Acquires VeraSci
July 26, 2021
Healthcare Services
WCG acquired VeraSci, a Durham-based provider of eClinical software and specialty scientific expertise for CNS-focused clinical trials, to deepen its CNS scientific capabilities and expand remote data capture and decentralized trial solutions. VeraSci will operate as WCG VeraSci and remain headquartered in North Carolina while retaining its leadership team.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.